sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
20-Sep-2014 18:08
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 451-475 out of 885.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>

Public Release: 24-Sep-2013
Pfizer Pharmaceuticals supports MARC project
The Council on Health Research for Development is pleased to acknowledge the support of Pfizer Pharmaceuticals on Phase II of the Mapping African Research Ethics Review and Medicines Regulatory Capacity project.
Pfizer Pharmaceuticals

Contact: Teresa Cullen
cullen@cohred.org
41-225-918-900
COHRED

Public Release: 23-Sep-2013
Clinical Infectious Diseases
CDC, Mass. General study reveals that preventing malaria in travelers to West Africa reduces health costs
Not only do US travelers to West Africa who consult health providers before they leave and take prescribed preventive medications substantially reduce their risk of contracting malaria, they also reduce costs to their health insurance providers and, in most cases, to themselves.
US Centers for Disease Control and Prevention

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 23-Sep-2013
New investment fund will advance late-stage vaccines, other global health technologies
A new $95 million international investment fund will for the first time allow individual and institutional investors the opportunity to finance late-stage global health technologies and advance interventions to fight such challenges in low-income countries as malaria, tuberculosis, HIV/AIDS and maternal and infant mortality.

Contact: Colleen Harris
colleen@colleenharris.co.uk
44-207-223-4512
Grand Challenges Canada

Public Release: 23-Sep-2013
Proceedings of the National Academy of Sciences
Cancer-killing cells controlled by epigenetic process, new study shows
Natural killer cells are white blood cells that can kill and contain cancer and infectious diseases. USC scientists have identified a specific enzyme that controls the development of natural killer cells in the body. Understanding how that enzyme affects the natural killer cell may help focus future drug development in the fight against cancer.
National Institutes of Health, Leukemia and Lymphoma Society

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences

Public Release: 19-Sep-2013
American Society of Clinical Pathology 2013 Annual Meeting in Chicago
New test enables early diagnosis of liver cancer
Researchers have found a way to make early liver cancer show its true colors.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 18-Sep-2013
University of Maryland researchers studying vaccine to prevent potential bird flu pandemic
Scientists at the University of Maryland School of Medicine's Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian influenza virus. The virus, called H7N9 influenza virus, emerged in China last spring. The study, sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will help prepare for the possibility of a global pandemic.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Bill Seiler
bseiler@umm.edu
410-328-8919
University of Maryland Medical Center

Public Release: 18-Sep-2013
School of Public Health receives $390,000 grant to study alcohol use among youth acquiring HIV
Dr. Monica Swahn, professor in the School of Public Health and associate vice president for researchat Georgia State University, has received a two-year, $390,000 grant from the National Institutes of Health to study the role of alcohol marketing and early alcohol use among African youth acquiring HIV.
National Institutes of Health

Contact: Frances Marine
francesmarine@gsu.edu
404-413-1504
Georgia State University

Public Release: 18-Sep-2013
Nature Communications
Scientists develop a new way to identify good fat
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at the University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
National Institutes of Health

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 18-Sep-2013
NIH prepares by funding new bird flu vaccine studies
Group Health Research Institute scientists are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China earlier this year, joining seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health to test vaccines to protect against the illness in adults. "Influenza viruses are constantly changing," said Lisa Jackson, M.D., M.P.H., a senior investigator at Group Health Research Institute.
National Institutes of Health

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute

Public Release: 18-Sep-2013
Journal of Infectious Diseases
Chronic inflammation of blood vessels could help explain high childhood mortality in malaria regions
Recurrent episodes of malaria cause chronic inflammation in blood vessels that might predispose to future infections and may increase susceptibility to cardiovascular disease, a Wellcome Trust study in Malawian children finds.
Wellcome Trust

Contact: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust

Public Release: 17-Sep-2013
WINFOCUS brings space station ultrasound from orbit to the ends of the Earth
Techniques developed for use aboard the International Space Station to provide remote imaging for health diagnostics are being adapted and used for people living in isolated, underdeveloped areas far from any hospital, where CT scans, MRIs and even simple X-ray exams are impossible.

Contact: Laura Niles
Laura.E.Niles@nasa.gov
281-244-7069
NASA/Johnson Space Center

Public Release: 17-Sep-2013
BioMed Central Public Health
Virginia Tech researchers help people in remote Africa respond to diarrheal disease
Researchers with Virginia Tech and the University of Florida undertook a study of diarrheal disease outbreaks in Botswana that relied only on the use of a simple questionnaire and existing hospital staff and infrastructure. The approach does not require increased human or economic resources, and it can give immediate insight into public health threats and disease outbreaks where this type of information otherwise would not be acquired.
National Science Foundation

Contact: Lynn Davis
davisl@vt.edu
540-231-6157
Virginia Tech

Public Release: 16-Sep-2013
Clinical Reviews in Allergy and Immunology
Gut microbes closely linked to proper immune function, other health issues
A new understanding of the essential role of gut microbes in the immune system may hold the key to dealing with some of the more significant health problems facing people in the world today, Oregon State University researchers say in a new analysis.

Contact: Dr. Natalia Shulzhenko
Natalia.shulzhenko@oregonstate.edu
541-737-1051
Oregon State University

Public Release: 16-Sep-2013
ChipCare's handheld analyzer attracts one of Canada's largest-ever healthcare angel investments
An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector. Phase II financing has closed, with an investment of CDN $2.05M to support ChipCare's continuing development and commercialization over the next three years.

Contact: Zina Nelku
zina.nelku@grandchallenges.ca
647-627-0195
Grand Challenges Canada

Public Release: 16-Sep-2013
Environmental Health Perspectives
Study shows projected climate change in West Africa not likely to worsen malaria situation
MIT study combines a new model of malaria transmission with global forecasts for temperature and rainfall to improve predictions of malaria with climate change.
National Science Foundation

Contact: Denise Brehm
brehm@MIT.EDU
617-253-8069
Massachusetts Institute of Technology

Public Release: 12-Sep-2013
American Heart Association High Blood Pressure Research Scientific Sessions 2013
Simple steps may identify patients that hold onto excess sodium
Getting a second urine sample and blood pressure measure as patients head out of the doctor's office appears an efficient way to identify those whose health may be in jeopardy because their bodies hold onto too much sodium, researchers report.
National Institutes of Health

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 12-Sep-2013
PLOS ONE
Research treats the fungus among us with nontoxic medicinal compound
A Kansas State University research team has found a breakthrough herbal medicine treatment for a common human fungal pathogen that lives in almost 80 percent of people. The team discovered a medicinal herb called Gymnema slyvestre is both nontoxic and blocks the virulence properties of a common fungus called Candida albicans.
Johnson Cancer Research Center

Contact: Govindsamy Vediyappan
gvediyap@k-state.edu
785-532-1529
Kansas State University

Public Release: 12-Sep-2013
Immunity
La Jolla Institute scientist identifies helper cells that trigger potent responses to HIV
A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology. La Jolla Institute scientist Shane Crotty, Ph.D., a respected vaccine researcher and member of one of the nation's top AIDS vaccine consortiums, showed that certain helper T cells are important for triggering a strong antibody response against HIV, the virus that causes AIDS.

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Public Release: 11-Sep-2013
Vaccine
Mosquito bites deliver potential new malaria vaccine
This study suggests that genetically engineered malaria parasites that are stunted through precise gene deletions (genetically attenuated parasites, or "GAP") could be used as a vaccine that protects against malaria infection.

Contact: Bryony Chinnery
44-203-176-4723
Elsevier

Public Release: 11-Sep-2013
Nature
Scripps Research Institute scientists solve century-old chemistry problem
Chemists at the Scripps Research Institute have found a way to apply a "foundational reaction" of organic chemistry to a stubborn class of chemicals, in a transformation that has been thought impossible for a century.
Eli Lilly, Boehringer Ingelheim

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 10-Sep-2013
Nature Medicine
2 common drugs may help treat deadly Middle East Respiratory Syndrome
Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is a deadly pneumonia that has killed more than 100 people, primarily in the Middle East. The new findings show that a combination of interferon-alpha 2b and ribavirin, drugs routinely used to treat hepatitis C, may be effective against this emerging disease.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Leila Gray
leilag@uw.edu
206-685-0381
University of Washington

Public Release: 10-Sep-2013
Lancet Infectious Diseases
NIH scientists develop new tests to detect drug-resistant malaria
Researchers have developed two tests that can discern within three days whether the malaria parasites in a given patient will be resistant or susceptible to artemisinin, the key drug used to treat malaria. The tests were developed by researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, working with French and Cambodian colleagues in Cambodia.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Sep-2013
Brown, University of Cape Town team up for HIV social science
Brown University and the University of Cape Town will collaborate under a new NIH grant on social science research and teaching to address HIV.
NIH/National Institute of Child Health and Human Development

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 8-Sep-2013
American Chemical Society's 246th National Meeting & Exposition
New 'Heroes of Chemistry' developed products that improve health and protect food supply
The scientists responsible for four inventions that affect the lives of millions of people around the globe will be inducted into the highly prized scientific "Hall of Fame" today as the latest Heroes of Chemistry chosen by the American Chemical Society, the world's largest scientific society.

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society

Public Release: 5-Sep-2013
Wellcome Trust renews support for major overseas program in Malawi
The Malawi-Liverpool-Wellcome Trust Clinical Research Programme -- one of the Wellcome Trust's major overseas programs -- is to receive around 14 million over 5 years in renewed funding, it is announced today.
Wellcome Trust

Contact: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust

Showing releases 451-475 out of 885.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>